v3.26.1
EQUITY (Tables)
6 Months Ended
Jun. 27, 2026
EQUITY  
Schedule of RSUs activity

​

​

​

​

​

​

​

​

​

​

​

Weighted average grant

​

​

Number of RSUs

​

date fair value per share

​

  ​ ​ ​

In thousands

  ​ ​ ​

U.S. dollars

Outstanding as of December 27, 2025

​

32,853

​

$

20

Granted

​

8,356

​

​

8

Vested

​

(1,450)

​

​

19

Forfeited

​

(1,535)

​

​

18

Outstanding as of June 27, 2026

​

38,224

​

$

17

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

Weighted average grant

​

​

Number of RSUs

​

date fair value per share

​

​

In thousands

​

U.S. dollars

Outstanding as of March 28, 2026

 

37,100

​

$

18

Granted

 

2,906

​

​

7

Vested

 

(1,054)

​

​

17

Forfeited

 

(728)

​

​

15

Outstanding as of June 27, 2026

 

38,224

​

$

17

Schedule of restricted shares activity

​

​

​

​

​

​

​

​

  ​ ​ ​

Number of Restricted

  ​ ​ ​

Grant date fair value per

​

​

Shares

​

share

​

​

In thousands

 

 U.S. dollars 

Outstanding as of December 27, 2025

​

—

 

$

—

Granted

​

23,652

 

​

9

Outstanding as of June 27, 2026

​

23,652

 

$

9

​

​

​

​

​

​

​

​

  ​ ​ ​

Number of Restricted 

  ​ ​ ​

Grant date fair value per

​

​

Shares

​

share

​

​

In thousands

​

U.S. dollars

Outstanding as of March 28, 2026

 

23,652

​

$

9

Outstanding as of June 27, 2026

 

23,652

​

$

9

Schedule of share-based compensation expenses

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Three Months Ended

​

Six Months Ended

U.S. dollars in millions

  ​ ​ ​

June 27, 2026

  ​ ​ ​

June 28, 2025

  ​ ​ ​

June 27, 2026

  ​ ​ ​

June 28, 2025

Cost of revenue

​

$

1

​

$

1

​

$

1

​

$

1

Research and development, net (1)

​

​

67

​

​

59

​

​

135

​

​

116

Sales and marketing

​

​

1

​

​

2

​

​

3

​

​

3

General and administrative

​

​

19

​

​

7

​

​

33

​

​

14

Total share-based compensation

​

$

88

​

$

69

​

$

172

​

$

134

​

(1)Not including R&D Law incentive grant related to ordinary income from sold RSUs as further detailed in Note 2 under Research and Development Incentives, which depends on the actual sale of the shares of common stock issued upon the conversion of RSUs.